The combination treatment of TRAIL and periplocin activated caspase 8, the key caspase for both mitochondria-dependent and-independent apoptotic signaling pathways, in TRAIL resistant HCC cells. This evidence concerns the gene TNFSF10 and hepatocellular carcinoma.